These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10690185)

  • 1. Reporting basal cell carcinoma: a survey of the attitudes of histopathologists.
    Milroy CJ; Richman PI; Wilson GD; Sanders R
    J Clin Pathol; 1999 Nov; 52(11):867-9. PubMed ID: 10690185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to routine handling of basal cell carcinoma re-excision specimens: a survey of Australian histopathologists.
    Warren LR; Karoo R; Caplash Y; Otto S
    Pathology; 2012 Jun; 44(4):331-6. PubMed ID: 22531342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes.
    Nguyen KP; Knuiman GJ; van Erp PE; Blokx WA; Peppelman M; Gerritsen MP
    J Am Acad Dermatol; 2017 Feb; 76(2):351-353.e3. PubMed ID: 28088999
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of typing basal cell carcinomas in predicting recurrence after surgical excision.
    Sloane JP
    Br J Dermatol; 1977 Feb; 96(2):127-32. PubMed ID: 843446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why classify basal cell carcinomas?
    Rippey JJ
    Histopathology; 1998 May; 32(5):393-8. PubMed ID: 9639112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting.
    McKenzie CA; Chen AC; Choy B; Fernández-Peñas P; Damian DL; Scolyer RA
    Pathology; 2016 Aug; 48(5):395-7. PubMed ID: 27311865
    [No Abstract]   [Full Text] [Related]  

  • 7. Margin Status in Shave Biopsies of Nonmelanoma Skin Cancers: Is It Worth Reporting?
    Schnebelen AM; Gardner JM; Shalin SC
    Arch Pathol Lab Med; 2016 Jul; 140(7):678-81. PubMed ID: 27116089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological variants of basal cell carcinoma.
    Strutton GM
    Australas J Dermatol; 1997 Jun; 38 Suppl 1():S31-5. PubMed ID: 10994469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basal cell carcinoma and rare form variants].
    Liersch J; Schaller J
    Pathologe; 2014 Sep; 35(5):433-42. PubMed ID: 25096987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological Sampling of Basal Cell Carcinoma Re-excision Specimens: How Much is Enough?
    Mesbah Ardakani N; Harvey NT; Mansford V; Wood BA
    Am J Dermatopathol; 2017 Nov; 39(11):824-828. PubMed ID: 29058693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current experience and attitudes to biomedical scientist cut-up: results of an online survey of UK consultant histopathologists.
    Simmons EJ; Sanders DS; Carr RA
    J Clin Pathol; 2011 Apr; 64(4):363-6. PubMed ID: 21345873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keloidal basal cell carcinoma. A new clinicopathological variant of basal cell carcinoma.
    Requena L; Martín L; Fariña MC; Piqué E; Escalonilla P
    Br J Dermatol; 1996 May; 134(5):953-7. PubMed ID: 8736345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unsupervised feature learning framework for basal cell carcinoma image analysis.
    Arevalo J; Cruz-Roa A; Arias V; Romero E; González FA
    Artif Intell Med; 2015 Jun; 64(2):131-45. PubMed ID: 25976208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classification of basal cell tumors].
    Hundeiker M
    Pathologe; 1982 Mar; 3(2):90-8. PubMed ID: 6283519
    [No Abstract]   [Full Text] [Related]  

  • 15. Approaches to routine handling of basal cell carcinoma re-excision specimens: a survey of Australian histopathologists.
    Warren LR; Karoo R; Caplash Y; Otto S
    Pathology; 2012 Jun; 44(4):331-336. PubMed ID: 28193337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The art and science of surgical margins for the dermatopathologist.
    Weinstein MC; Brodell RT; Bordeaux J; Honda K
    Am J Dermatopathol; 2012 Oct; 34(7):737-45. PubMed ID: 23000878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keloidal basal cell carcinoma: should it be considered a distinct entity?
    Balestri R; Misciali C; Zampatti C; Odorici G; Balestri JA
    J Dtsch Dermatol Ges; 2013 Dec; 11(12):1196-8. PubMed ID: 23889902
    [No Abstract]   [Full Text] [Related]  

  • 18. Whole specimen intraoperative frozen section analysis. Experience with 1082 basal cell carcinomas.
    Kedilioglu MA; Bos PG; De Jong K; Noordzij NA; Kibbelaar RE; Lapid O; Mouës CM
    Eur J Surg Oncol; 2018 Jan; 44(1):157-162. PubMed ID: 29198817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms.
    Sexton M; Jones DB; Maloney ME
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1118-26. PubMed ID: 2273112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excision margins for nonmelanotic skin cancer.
    Thomas DJ; King AR; Peat BG
    Plast Reconstr Surg; 2003 Jul; 112(1):57-63. PubMed ID: 12832877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.